NMN Explained: What It Does, Dosage, and What the Science Says

Short answer first. NMN is a form of vitamin B3 that your body turns into NAD+, a molecule every cell uses for energy and repair.

Oral NMN does raise NAD+ in your blood. That part is settled. What is not settled is the part that matters: after 15 human trials, the effects on strength, blood sugar, cholesterol and body composition have mostly been zero.

Most trials used 250 to 500 mg a day, and the safety record over 14 days to 24 weeks looks clean. So the honest verdict is a well-tolerated supplement with a real mechanism and, so far, unimpressive results.

TL;DR

• NMN is a B3-derived molecule your body converts into NAD+.
• Oral NMN reliably raises NAD+ in the blood, even at 250 mg a day.
• Human trials have used 250 to 2,000 mg per day, mostly 250 to 500 mg.
• Meta-analyses find no change in muscle mass, grip strength, fasting glucose, HbA1c or lipids.
• The only real signals are small: slightly lower diastolic blood pressure, better sleep quality, faster sit-to-stand.
• Safety data covers up to 24 weeks. No one has run a multi-year trial.
• NMN does not replace training, protein, sleep or treatment for a diagnosed condition.

What NMN is and how it works

NMN stands for nicotinamide mononucleotide. It is built from nicotinamide, one of the forms of vitamin B3, plus a ribose and a phosphate group. Your body uses it as a building block.

NAD+ (nicotinamide adenine dinucleotide) is the molecule your cells run on. It shuttles electrons in the mitochondria, and it fuels the enzymes that repair DNA and calm inflammation: the sirtuins, the PARPs, and CD38. All of them consume NAD+ while they work.

Your body makes NAD+ from several precursors, and the last step in that chain is turning NMN into NAD+ by an enzyme called NMNAT. NMN sits one step from the finish line, which is the entire marketing pitch. It is a “closer” precursor than nicotinamide riboside (NR), which has to be converted into NMN first.

That difference sounds bigger than it is. In humans, both end up raising blood NAD+ [11]. NAD+ itself is too large to survive digestion as a supplement, which is why every product on the shelf is a precursor, not NAD+.

For the wider picture on what NAD+ is and whether the decline with age is as dramatic as the marketing charts suggest, read our NAD+ guide for people over 40.

Does oral NMN raise NAD+ in humans? (yes)

This is the one claim in the whole category that holds up.

A randomized, double-blind, placebo-controlled trial in healthy older men gave 250 mg of NMN a day for 6 or 12 weeks. Whole-blood analysis showed NAD+ and its metabolites went up significantly, and the supplement was well tolerated [1].

“Chronic oral NMN supplementation can be an efficient NAD+ booster for preventing aging-related muscle dysfunctions in humans.”

A second double-blind trial in older adults found the same rise in blood NAD+ after 12 weeks [7]. So the “does it even work” question is answered at the blood level.

The catch is what that number means. Blood NAD+ is not a health outcome, and commercial NAD+ tests are not standardized. A higher blood level is a marker, not a benefit. Our pillar on NAD+ after 40 covers why the “check your NAD+” pitch deserves suspicion.

What the human trials show

Muscle, strength and physical function

This is the most disappointing part.

A 2025 systematic review and meta-analysis pooled the trials that measured muscle outcomes in people aged 60 to 83. NMN had no significant effect on skeletal muscle index, hand grip strength, gait speed or the five-times sit-to-stand test [3].

The authors did not hedge. Every confidence interval crossed zero.

An earlier meta-analysis of 9 trials and 412 participants was more positive: it reported a small improvement in gait speed and a modest fall in ALT [4]. The best signal on insulin resistance came at lower doses.

Read the two together and the pattern is familiar: benefits appear in some studies, vanish in others, and the pooled effects shrink as more trials are added.

Even the positive trials are modest by their own admission. The 2022 trial reported only “nominally significant” improvements in gait speed and left grip, and the authors called for larger studies to confirm them [1]. Nominal is the word researchers use when a result could easily be chance.

Blood pressure and metabolic markers

The largest safety review to date pooled 15 trials with NMN doses from 250 to 2,000 mg a day, running from 14 days to 24 weeks. It found no effect on body weight, BMI, fasting glucose, HbA1c, lipid profiles or systolic blood pressure.

Diastolic blood pressure fell slightly, and insulin resistance showed a downward trend that did not reach significance [2].

A separate meta-analysis of 10 trials focused on blood pressure found the same small diastolic effect, plus a reduction in systolic pressure only in people aged 60 and older [5].

“Our findings provide preliminary and suggestive evidence that NMN supplementation may be associated with a small reduction in resting DBP.”

Preliminary and suggestive. Two millimetres of mercury is not a treatment, and neither review claims it is.

Sleep, fatigue and how you feel day to day

The one outcome where NMN keeps showing something is how people feel and move.

A 12-week trial in 108 older adults gave 250 mg of NMN either in the morning or the afternoon. The afternoon group had the largest improvement in the sit-to-stand test and in daytime drowsiness, but every group improved, including placebo [6]. That last detail matters. It means part of the benefit came from being in a trial at all.

A separate 12-week double-blind study in older adults found blood NAD+ rose, walking speed was maintained, and sleep quality improved [7].

None of this is a cure for a bad night’s sleep, and none of it should stop you from fixing the basics first: light, timing, caffeine and alcohol. Our guide to better sleep after 40 does that work properly.

Dosage: what the trials used

Trial type	Dose	Duration	Outcome
Muscle and strength meta-analysis	250 mg/day	12 weeks	No effect [3]
Safety meta-analysis (15 trials)	250–2,000 mg/day	14 days–24 weeks	No adverse-event signal [2]
Blood pressure meta-analysis	Mostly 250–500 mg/day	8–12 weeks	Small diastolic drop [5]
Sleep and physical function	250 mg/day	12 weeks	Better sit-to-stand, less drowsiness [6]

Practical version: 250 to 500 mg a day is the range with the most human data behind it. Higher doses up to 2,000 mg have been tested and did not show better results.

Give it 8 to 12 weeks before you decide, because that is the shortest window any of these trials ran. And judge it on something you can measure, like how you sleep or what you lift, not on how you feel on day three.

NMN vs NR vs nicotinamide

	What it is	Human evidence	Typical dose
NMN	B3-derived, one step from NAD+	Raises blood NAD+, null on most outcomes [1][2]	250–500 mg/day
NR	B3-derived, converted to NMN first	Raises blood NAD+, similar null pattern [11]	300–1,000 mg/day
Nicotinamide	Plain B3, cheapest precursor	Raises NAD+, but gram doses carry liver risk	500 mg/day, not grams
Niacin	B3 that flushes	Raises NAD+, used for cholesterol historically	Doctor-guided only

The head-to-head human data are thin, which is the honest reason to pick either NMN or NR: both raise NAD+, neither has proven outcomes [11]. For the one direct comparison that exists, see NR vs NMN. Plain nicotinamide is far cheaper and does the same basic job, but the doses people push for NAD+ are high enough to be a real liver concern. Niacin at cholesterol doses is a prescription-level decision.

Safety and side effects

The 2026 safety meta-analysis is the best answer available: across 15 trials and doses up to 2,000 mg a day, NMN did not increase overall adverse events, serious adverse events, or liver enzymes [2]. The sublingual-versus-oral study reported no adverse events on either route [8].

What is unknown:

• Long term. The longest human data cover 24 weeks. Nobody has published a 5-year NMN trial.
• Cancer risk. Rodent studies point in both directions. One 2026 mouse study found high-dose NMN enhanced anti-tumor immunity by reshaping tumor-associated macrophages [9], while other animal work has raised the opposite worry that boosting NAD+ could feed certain tumors. In humans, this is unstudied. If you have a cancer history, treat NMN as a question for your oncologist, not a supplement.
• Pregnancy and breastfeeding. Not studied. Skip it.
• Interactions. No trial has tested NMN against prescription medication.

How to choose an NMN supplement

Four checks, in order:

1. Dose per capsule in the trial range. 250 to 500 mg. If the label hides the amount in a “proprietary blend”, walk away.
2. Third-party testing. Look for a named lab, a batch number, and a certificate you can request.
3. Regulatory status in your country. In the US, the FDA reversed its 2022 position and confirmed in late 2025 that NMN is lawful in dietary supplements. In the EU it is still treated as an unauthorised novel food, though EFSA issued a positive safety opinion on one 300 mg product in May 2026. In the UK it is sold under transitional novel-food rules with no authorised health claims allowed.
4. Price sanity. NMN is not a rare ingredient. A bottle costing 10 times more than another is a branding choice, not a chemistry one.

Where to start

If you want to try NMN, pick a plain 250 mg capsule from a brand that publishes third-party testing, take one a day, and give it 12 weeks. Track sleep and how you feel, not your blood NAD+ level.

If you are looking for something with a clearer signal in the human data, urolithin A has more consistent muscle-function results, and protein, resistance training and sleep still beat both.

FAQ

Should you take NMN in the morning or at night?

There is no rule, and timing has never been shown to change health outcomes. The 12-week sleep trial dosed in the afternoon and got the best result, but the differences between groups were small [6]. If NMN keeps you awake, move it earlier.

How long does NMN take to work?

Blood NAD+ rises within weeks, which is why trials measure it early. For anything you can feel, the trials ran 12 to 24 weeks and mostly found nothing. Give it 8 to 12 weeks and then decide honestly.

Does NMN have to be sublingual or enteric-coated?

The marketing says sublingual absorbs better. A 2026 crossover study in healthy men found sublingual dosing did raise certain terminal metabolites faster in the first hour, but blood levels of NMN, nicotinamide and NAD+ did not differ between sublingual and oral routes [8]. Paying extra for sublingual is not supported by that data.

Can you get NMN from food?

Small amounts occur in edamame, broccoli, avocado, cucumber and milk. The quantities are far below trial doses, so no realistic diet delivers 250 mg. Food sources are a nice fact, not a strategy.

Should you take NMN with resveratrol or TMG?

It is a popular stack and it has no human randomized trial behind it. TMG is sometimes added to offset the methylation drain of high-dose nicotinamide, which is a different molecule at much higher doses. Stacking unproven supplements multiplies cost, not evidence.

Does NMN help you live longer?

No human trial has ever measured lifespan on NMN, and none is likely to, because that would take decades. The claims come from animal studies. In humans, the measurable endpoints are the ones above, and they are mostly flat [2][3].

References & sources (12)

References

1. Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging, 2022. PMID 35927255
2. Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. Nutrients, 2026. PMID 42514320
3. The Effect of Nicotinamide Mononucleotide and Riboside on Skeletal Muscle Mass and Function: A Systematic Review and Meta-Analysis. Journal of Cachexia, Sarcopenia and Muscle, 2025. PMID 40275690
4. Effects of Nicotinamide Mononucleotide Supplementation on Muscle and Liver Functions Among the Middle-aged and Elderly: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current Pharmaceutical Biotechnology, 2025. PMID 39185644
5. Effects of Nicotinamide Mononucleotide Supplementation on Blood Pressure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Nutrients, 2026. PMID 41901064
6. Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study. Nutrients, 2022. PMID 35215405
7. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. GeroScience, 2024. PMID 38789831
8. Sublingual NMN administration increases early circulating terminal catabolites 2PY and 4PY compared with oral administration in healthy adult men. Scientific Reports, 2026. PMID 42304075
9. Nicotinamide mononucleotide enhances anti-tumor effect by resetting macrophages toward the inflammatory M1-like phenotype. Molecular Therapy Oncology, 2026. PMID 42179971
10. Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial. Nature Medicine, 2026. PMID 42056497
11. Precursor comparisons for the upregulation of nicotinamide adenine dinucleotide. Aging Medicine, 2021. PMID 34553119
12. Effect of Nicotinamide Mononucleotide on Retinal Thickness of Older Patients With Diabetes Mellitus: A Placebo-Controlled, Double-Blind Study. Geriatrics & Gerontology International, 2026. PMID 42082179

This article is for general information and is not medical advice. It does not replace the advice of your doctor or pharmacist. Talk to a qualified clinician before starting any supplement, especially if you take prescription medication, have a health condition, or are pregnant or breastfeeding.